ScreenerHero

ZVSA ZyVersa Therapeutics Inc. Common Stock

NAS · US · Healthcare · Biotechnology · zyversa.com
0.0990USD0.00%Mkt Cap: 801496 $P/E: —

ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It develops drug development platforms, including Cholest…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$128.08BUSDP/E 29.4
MRNA
Moderna, Inc.
$78.44BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.40BUSDP/E 18.4
ARGX
argenx SE
$57.03BUSDP/E 37.3
ARGX
argenx SE
$58.08BUSDP/E 35.4
UCB
UCB SA
$42.24BUSDP/E 18.0
RVMD
Revolution Medicines, Inc.
$43.05BUSD
ONC
BeOne Medicines AG
$41.41BUSDP/E 65.1
RPRX
Royalty Pharma plc
$32.80BUSDP/E 30.2
ALNY
Alnylam Pharmaceuticals, Inc.
$30.03BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.10BUSD
BNTX
BioNTech SE
$23.93BUSD
INCY
Incyte Corporation
$22.99BUSDP/E 14.5
GMAB
Genmab A/S
$22.27BUSDP/E 30.7
GMAB
Genmab A/S
$22.54BUSDP/E 28.9
INSM
Insmed Incorporated
$22.22BUSD
ASND
Ascendis Pharma A/S
$15.03BUSDP/E 17.5
JAZZ
Jazz Pharmaceuticals plc
$15.01BUSDP/E 15.8
EXEL
Exelixis, Inc.
$14.48BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$14.32BUSD

Key Statistics

Company
Market Cap801.50K USD
Enterprise Value1.56M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-24.95M USD
Revenue/Share—
Last Price0.0990 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees6
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.02
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B-0.05
EPS (TTM)-2.70
EPS (Forward)-4.80
52W Range
0.09502% of range0.3000
52W High0.3000 USD
52W Low0.0950 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE201.44%
ROA-7172.26%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.11M USD
CapEx (TTM)—
FCF Margin—
FCF Yield-271.70%
Net Debt897.34K USD
Net Debt/EBITDA—
Balance Sheet
Debt/Equity—
Current Ratio0.05
Quick Ratio0.02
Book Value/Sh-1.75 USD
Cash/Share0.04 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateApr 26, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.8.10M
Float8.09M
Insiders0.02%
Institutions5.15%
Short Interest
Short Ratio0.0d
Short % Float6.52%
Short % Out.6.51%
Shares Short517.01K
Short (prev mo.)188.93K
Technical
SMA 500.1019 (-2.8%)
SMA 2000.1672 (-40.8%)
Beta0.84
S&P 52W Chg16.45%
Avg Vol (30d)2.31K
Avg Vol (10d)10.06K
Technical Indicators
RSI (14)40.6
MACD-0.0058
MACD Signal-0.0074
MACD Hist.+0.0016
BB Upper0.1075 USD
BB Middle0.0999 USD
BB Lower0.0923 USD
BB Width15.18%
ATR (14)0.0070 USD
Vol Ratio (20d)1.21x